Request Free Sample
×
Glucose 6 Phosphate Dehydrogenase Deficiency Market
ID: MRFR/HC/35420-HCR
100 Pages
October 2025
Marktforschungsbericht zu Glukose-6-phosphat-Dehydrogenase-Mangel nach Diagnosetyp (Enzymtest, DNA-Sequenzierung, Gentests), nach Behandlungstyp (Bluttransfusion, Folsäureergänzung, Hydroxyharnstofftherapie), nach Endbenutzer (Krankenhäuser, Diagnoselabore, Forschungseinrichtungen), nach Verabreichungsart (oral, intravenös, intramuskulär) und nach Region (Nordamerika, Europa, Südamerika, Asien-Pazifik, Naher Osten und Afrika) - Prognose bis 2034
Zu den wichtigsten Unternehmen im Glucose 6 Phosphate Dehydrogenase Deficiency Market-Markt gehören
Berichtsumfang
FAQs
What is the current market valuation of the Glucose-6-Phosphate Dehydrogenase Deficiency Market?
As of 2024, the market valuation was 2.066 USD Billion.
What is the projected market size for the Glucose-6-Phosphate Dehydrogenase Deficiency Market by 2035?
The market is expected to reach a valuation of 3.715 USD Billion by 2035.
What is the expected CAGR for the Glucose-6-Phosphate Dehydrogenase Deficiency Market during the forecast period?
The market is projected to grow at a CAGR of 5.48% from 2025 to 2035.
Which companies are the key players in the Glucose-6-Phosphate Dehydrogenase Deficiency Market?
Key players include Pfizer Inc, Bristol-Myers Squibb Company, Bayer AG, Roche Holding AG, Novartis AG, Sanofi S.A., GlaxoSmithKline plc, Amgen Inc, and AbbVie Inc.
What are the main segments of the Glucose-6-Phosphate Dehydrogenase Deficiency Market?
The main segments include Diagnosis Type, Treatment Type, End User, and Mode of Delivery.
What was the market size for the Enzymatic Assay segment in 2024?
In 2024, the Enzymatic Assay segment was valued at 0.826 USD Billion.
How much is the Genetic Testing segment projected to be worth by 2035?
The Genetic Testing segment is expected to reach 1.118 USD Billion by 2035.
What is the projected market size for Blood Transfusion treatments by 2035?
Blood Transfusion treatments are anticipated to grow to 1.482 USD Billion by 2035.
Which end user segment is expected to have the highest valuation by 2035?
The Hospitals segment is projected to reach 1.5 USD Billion by 2035.
What is the expected growth for the Intravenous mode of delivery by 2035?
The Intravenous mode of delivery is likely to grow to 1.115 USD Billion by 2035.
Kostenloses Muster herunterladen
Bitte füllen Sie das folgende Formular aus, um ein kostenloses Muster dieses Berichts zu erhalten
Customer Stories
“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”
Noah Malgeri
Co-Founder
“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”
Joseph Aguayo
Sales Operations & Pricing Manager
“Thanks for sending the report it gives us a good global view of the Betaïne market.”
Peter Groot koerkamp
Account and Business Manager
“Thank you, this will be very helpful for OQS.”
La Terria Dodd
Program Support Specialist
“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”
Younghwan Choi
Senior Retail Manager
“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”
Mark Irwin
Management Consultant
“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”
Rob Kooiker
Group Product Manager HVAC & Fire Protection GMA
“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”
Akif Moroglu
Strategy & Business Development Director
Fallstudie
Aerospace & Defense
Einen Kommentar hinterlassen